Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro

Background: Although mechanistic target of rapamycin (mTOR) inhibitors, such as temsirolimus, show promise in treating bladder cancer, acquired resistance often hampers efficacy. This study evaluates mechanisms leading to resistance. Methods: Cell growth, proliferation, cell cycle phases, and cell c...

Descripción completa

Detalles Bibliográficos
Autores principales: Juengel, Eva, Natsheh, Iyad, Najafi, Ramin, Rutz, Jochen, Tsaur, Igor, Haferkamp, Axel, Chun, Felix K.-H., Blaheta, Roman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627393/
https://www.ncbi.nlm.nih.gov/pubmed/31167517
http://dx.doi.org/10.3390/cancers11060777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627393/
https://www.ncbi.nlm.nih.gov/pubmed/31167517
http://dx.doi.org/10.3390/cancers11060777

Ejemplares similares